Impact of pretreatment hemoglobin levels on tumor response, microvessel count and Ki67 expression in breast cancer patients undergoing primary chemotherapy.

被引：0
|
作者：
Bottini, A
Berruti, A
Brizzi, MP
Allevi, G
Bersiga, A
Generali, D
Aguggini, S
Bolsi, G
Bonardi, S
Alquati, P
Dogliotti, L
机构：
[1] Azienda Osped, Ist Ospitalieri, Cremona, Italy
[2] Azienda Osped San Luigi, Orbassano, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
223
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] KI67 Expression in Primary Male Breast Cancer
    Erices-Leclercq, Melanie
    Rudlowski, Christian
    Baldus, Stephan
    Foerster, Frank
    Schroeder, Lars
    Stiller, Franziska
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 27 - 28
  • [2] Breast cancer: response to primary chemotherapy and biological parameters (ER, PgR, Ki67)
    Donadio, M
    Manzin, E
    Bumma, C
    BREAST, 1997, 6 (05): : P918 - P918
  • [3] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
    von Minckwitz, Gunter
    Schmitt, Wolfgang D.
    Loibl, Sibylle
    Mueller, Berit M.
    Blohmer, Jens U.
    Sinn, Bruno V.
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Tesch, Hans
    Hilfrich, Joern
    Huober, Jens
    Fehm, Tanja
    Barinoff, Jana
    Ruediger, Thomas
    Erbstoesser, Erhard
    Fasching, Peter A.
    Karn, Thomas
    Mueller, Volkmar
    Jackisch, Christian
    Denkert, Carsten
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
  • [4] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Peter A Fasching
    Katharina Heusinger
    Lothar Haeberle
    Melitta Niklos
    Alexander Hein
    Christian M Bayer
    Claudia Rauh
    Ruediger Schulz-Wendtland
    Mayada R Bani
    Michael Schrauder
    Laura Kahmann
    Michael P Lux
    Johanna D Strehl
    Arndt Hartmann
    Arno Dimmler
    Matthias W Beckmann
    David L Wachter
    BMC Cancer, 11
  • [5] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    BMC CANCER, 2011, 11
  • [6] Evaluation of pretherapeutic Ki67 as predictive marker for response to neoadjuvant chemotherapy in patients with primary breast cancer.
    Farr, Alex
    Weber, Myriam
    Pfeiler, Georg
    Oppolzer, Elisabeth
    Salama, Mohammed
    Bago-Horvath, Zsuzsanna
    Seifert, Michael
    Singer, Christian F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Difference in Ki67 and thymidylate synthase expression in primary tumor compared with metastatic nodes in breast cancer patients
    Calascibetta, A.
    Cabibi, D.
    Rausa, L.
    Aragona, F.
    Barresi, E.
    Martorana, A.
    Sanguedolce, R.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (9-11): : 1193 - 1196
  • [8] Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
    Aleskandarany, M. A.
    Green, A. R.
    Ashankyty, I.
    Elmouna, A.
    Diez-Rodriguez, M.
    Nolan, C. C.
    Ellis, I. O.
    Rakha, E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 287 - 295
  • [9] Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer
    M. A. Aleskandarany
    A. R. Green
    I Ashankyty
    A Elmouna
    M Diez-Rodriguez
    C. C. Nolan
    I. O. Ellis
    E. A. Rakha
    Breast Cancer Research and Treatment, 2016, 158 : 287 - 295
  • [10] Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67
    Boughey, Judy C.
    Hoskin, Tanya L.
    Goetz, Matthew P.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 5747 - 5756
12345